Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma

R. Villa, C. Della Porta, M. Folini, M. G. Daidone, N. Zaffaroni

Research output: Contribution to journalArticlepeer-review

Abstract

To investigate the regulatory mechanisms of telomerase activity in human melanoma cells, we assessed the enzyme's catalytic activity and the expression of the telomerase subunits, the human telomerase RNA, the human telomerase-associated protein, and the human telomerase reverse transcriptase, in 52 melanoma lesions. Eight normal skin specimens were also studied. Telomerase activity was detected in 84.6% of melanomas, whereas all skin specimens were telomerase negative. Human telomerase-associated protein mRNA and human telomerase RNA were constitutively expressed in all melanoma and skin specimens. Although at a variable level of expression, human telomerase reverse transcriptase mRNA was detected in all but one melanomas, whereas it was never present in skin samples. Reverse transcriptase-polymerase chain reaction experiments were performed using primers within the reverse transcriptase domain of human telomerase reverse transcriptase and revealed the presence of multiple alternatively spliced transcripts in melanoma specimens. Among the 44 telomerase-positive melanomas, one showed the full-length transcript alone whereas in all other specimens a full-length message was present with different combinations of alternatively spliced variants. In these tumors the expression of the full-length transcript was generally equal to or higher than that of the alternatively spliced variants. The ratio full-length transcript to alternatively spliced species ranged from 0.6 to 5.26, with a median value of 1.18. Among the seven telomerase-negative melanomas, one displayed the β deletion transcript alone, whereas in the remaining six tumors weak expression of the full-length transcript and a more abundant level of alternatively spliced transcripts were found. In these cases human telomerase reverse transcriptase ratio ranged from 0.09 to 1.1, with a median value of 0.40. The results suggest that transcription and alternative splicing of human telomerase reverse transcriptase are regulatory mechanisms controlling telomerase activity in melanoma.

Original languageEnglish
Pages (from-to)867-873
Number of pages7
JournalJournal of Investigative Dermatology
Volume116
Issue number6
DOIs
Publication statusPublished - 2001

Keywords

  • Alternatively spliced human telomerase reverse transcriptase variants
  • Telomerase subunits

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma'. Together they form a unique fingerprint.

Cite this